• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Danielle Kirsh

FDA recognizes latest ISO 14971 as medical device consensus standard

January 16, 2020 By Danielle Kirsh

Emergo-UL-logo

By Mark Leimbeck and Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted Recognized Consensus Standard status to the third edition of the ISO 14071 risk management standard for medical devices and IVD products. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Neurelis wins FDA approval for seizure rescue nasal spray

January 13, 2020 By Danielle Kirsh

neurelis-logo

Neurelis today said it won FDA approval for its Valoco seizure rescue nasal spray. Valtoco is approved to use by a care partner outside of a medical setting to treat intermittent, stereotypic episodes of seizure activity. It is designed for people with epilepsy aged 6 or older. Valtoco also uses the company’s Intravail formula for […]

Filed Under: Drug-Device Combinations Tagged With: Neurelis Inc.

TriSalus launches TriNav Infusion System

January 13, 2020 By Danielle Kirsh

TriSalus-logo

TriSalus this week launched its TriNav Infusion System. The infusion system is powered by the company’s Pressure-Enabled Drug Delivery (PEDD) approach with SmartValve technology and is designed to help with the infusion barriers that can limit therapeutic uptake in solid tumors. It gives interventional radiologists intravascular tumor access and improved traceability, compatibility with standard angiographic […]

Filed Under: Drug-Device Combinations Tagged With: trisaluslifesciences

Tandem Diabetes Care appoints executive VP of strategy and corporate development

January 10, 2020 By Danielle Kirsh

Tandem Diabetes Care - updated logo

Tandem Diabetes Care (NSDQ:TNDM) this week said it appointed Elizabeth Gasser as executive VP of strategy and corporate development. Prior to joining the company, Gasser was an independent adviser for Tandem Diabetes Care. She has also led the corporate strategy function at Qualcomm and has held a number of leadership roles at Openwave Systems. “Liz has […]

Filed Under: Business/Financial News, Diabetes Tagged With: Tandem Diabetes Care

Prasco launches generic NuvaRing

December 17, 2019 By Danielle Kirsh

prasco

Prasco this week said it launched its authorized generic NuvaRing. The generic etonogestrel/ethinyl vaginal ring is a small, flexible vaginal ring that is used by women as a form of birth control. The NuvaRing releases a continuous low dose of hormones for three weeks at a time. “We are proud to launch the authorized generic […]

Filed Under: Women's Health Tagged With: Merck, Prasco

Medicina recalls IV Luer Slip syringes

December 12, 2019 By Danielle Kirsh

medicina

Medicina is recalling its IV Luer Slip syringe due to incorrect packaging. According to the company, syringes were incorrectly packaged with a needle, which means they are not sterile and could cause a needle stick injury. The device affected by the recall is 3ml Luer Slip syringe without needle with Medicina product code IVS03, NHS […]

Filed Under: Drug-Device Combinations, Recalls Tagged With: Medicina

Eitan Group signs service agreement with Integrated Medical Systems

December 11, 2019 By Danielle Kirsh

eitan-group-logo

The Eitan Group this week said it signed a service partnership with integrated Medical Systems. Through the agreement, Integrated medical Systems will be the service provider for the Eitan Group’s Sapphire infusion pumps that are used in hospital-based and alternate site infusion. “For over two decades, IMS has worked to provide innovative solutions for alternate […]

Filed Under: Drug-Device Combinations Tagged With: Eitan Group, Integrated Medical Systems

FDA details framework for abbreviated 510(k) medical device review pathway

December 10, 2019 By Danielle Kirsh

Emergo-UL-logo

By Stewart Eisenhart, Emergo Group The US Food and Drug Administration has published a high-level framework for its Safety and Performance Based Pathway, an expedited 510(k) premarket review process for qualifying medical devices announced earlier in 2019. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Aptar wins FDA clearance for ready-to-use seizure treatment device

December 9, 2019 By Danielle Kirsh

aptar-logo

AptarGroup today said it won FDA approval for its Unidose Liquid System that treats acute repetitive seizures in people who have epilepsy. The Unidose Liquid System is a device that delivers a nasal rescue treatment that is ready-to-use when and where a seizure cluster occurs. “This approval and successful market launch further demonstrate the broad […]

Filed Under: Drug-Device Combinations, Pharmaceuticals Tagged With: aptarpharma, epilepsy

Leo Pharma, Portal Instruments partner to develop needle-free drug delivery device

December 5, 2019 By Danielle Kirsh

leo-portal-collab

Leo Pharma and Portal Instruments this week announced a global collaboration and license agreement to develop a needle-free drug delivery system. Through the agreement, Leo Pharma’s investigational and approved medicines will be used in combination with Portal’s needle-free drug delivery system. Portal’s needle-free jet injector platform allows patients to self-administer biologics without needles. It features […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: Leo Pharma, portal instruments

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Interim pages omitted …
  • Page 54
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS